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Endothelin-1 (ET-1) is a potent vasoconstrictor pep-
tide originally isolated and purified from the condi-
tioned medium of cultured porcine aortic endothelial
cells [1], and it has also been shown to process a wide
spectrum of biological activities in kidneys [2]. Recent
studies indicate that ET-1 may also play an important
role in glomerular diseases [3]. ET-1 induces mesan-
gial cell proliferation and the production of extracel-
lular matrix [4], both of which are important in the
pathogenesis of glomerulosclerosis.
Angiotensin II (Ang-II), the main peptide of the
renin–angiotensin system, is a renal growth factor,
inducing hyperplasia/hypertrophy depending on the
type of cell. Ang-II is also an important vasoactive
peptide involved in the formation of glomeruloscle-
rosis. All components of the renin–angiotensin system,
including precursors and enzymes required for the
formation and degradation of the biologically active
Kaohsiung J Med Sci August 2006 • Vol 22 • No 8 371
© 2006 Elsevier. All rights reserved.
Received: December 22, 2005 Accepted: April 25, 2006
Address correspondence and reprint requests to: Dr Mei-Chuan
Kuo, Division of Nephrology, Department of Internal Medicine,
Kaohsiung Medical University, 100 Tzyou 1st Road, Kaohsiung
807, Taiwan.
E-mail: mechku@kmu.edu.tw
EFFECTS OF SPECIFIC ENDOTHELIN-1 RECEPTOR
ANTAGONISTS ON PROLIFERATION AND
FIBRONECTIN PRODUCTION OF GLOMERULAR
MESANGIAL CELLS STIMULATED WITH
ANGIOTENSIN II
Hung-Tien Kuo, Shyi-Jang Shin,1 Mei-Chuan Kuo, and Hung-Chun Chen
Divisions of Nephrology and 1Endocrinology, Department of Internal Medicine, 
Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
Angiotensin II (Ang-II) is a potent vasoactive hormone, which plays an important role in the
pathogenesis of glomerulosclerosis. Ang-II activates many cytokine systems in the kidney. Recent
studies indicate that Ang-II is closely related to the activation of the endothelin-1 (ET-1) system.
The present study was designed to measure the [H3]-thymidine uptake and fibronectin produc-
tion of cultured rat mesangial cells stimulated with Ang-II, and to evaluate the effects of specific
ET-1 receptor antagonists, BQ123 (type A receptor antagonist) and IRL1038 (type B receptor
antagonist) on the cells. ET-1 was measured by radioimmunoassay and fibronectin by Western
blot analysis. The results were as follows: (1) Ang-II enhanced ET-1 production, [H3]-thymidine
uptake, number of cells, and fibronectin production of mesangial cells; (2) all the baseline [H3]-
thymidine uptake, number of cells, and fibronectin production of mesangial cells can be partly
suppressed by BQ123, but not by IRL1038; (3) the increment of Ang-II-enhanced number of cells
can be partly suppressed by BQ123, but not by IRL1038; and (4) the increment of Ang-II-enhanced
fibronectin production can be partly suppressed by both BQ123 and IRL1038. Our results indicate
that Ang-II is an active stimulant for the proliferation and fibronectin production of mesangial
cells, and the effect is partly suppressed mainly by ET-1 type A receptor antagonists.
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forms of angiotensin, as well as different receptors,
have been identified in the kidney [5,6]. Recent studies
indicate that the effects of Ang-II may be mediated 
by ET-1, because the use of angiotensin-converting
enzyme (ACE) inhibitor or angiotensin receptor
antagonists blunts or inhibits the activation of the
endothelin system [7]. However, Ang-II also activates
other cytokine systems that may activate the glomeru-
lar cells consequently. Therefore, the importance of
ET-1 in mediating the effect of Ang-II on glomerular
cells remains unclear. Mesangial cell, the major intrin-
sic cell in the glomerulus, is one of the targets of Ang-
II in various renal diseases. In this study, we measured
the effects of specific ET-1 receptor antagonists, BQ123
(type A receptor antagonist) and IRL1038 (type B
receptor antagonist) on the [H3]-thymidine uptake
and fibronectin production of cultured rat glomeru-
lar mesangial cells stimulated with Ang-II.
MATERIALS AND METHODS
Culture of mesangial cells
Mesangial cells were isolated and cultured from rat
renal glomeruli according to the methods described
previously [8]. Briefly, glomeruli were harvested from
six to eight male Sprague–Dawley rats (150–200 g) by
sieving the renal cortices, which were then digested
with 0.25% trypsin and 0.05% collagenase. The diges-
ted glomeruli were incubated at 37°C in RPMI-1640
medium containing 20% fetal calf serum (FCS), peni-
cillin (100 U/mL), streptomycin (100 μg/mL), and
insulin (0.6 U/mL). After 2–3 weeks, mesangial cells
appeared and were characterized. On phase contrast
microscopy, the cells were stellate or spindle-shaped in
appearance, and in postconfluent culture they piled
and formed small nodules. The nodules were sensitive
to mitomycin C, but not to aminonucleoside of puro-
mycin, and they contracted in response to Ang-II. In
addition, the cells failed to stain for Ia and leukocyte
common antigen. The cells were passaged every 4–6
days. Cells were starved by incubating in a medium
containing 0.5% FCS for 24 hours before the reagents
were added. The animal experiment was approved by
the animal committee of Kaohsiung Medical University.
Experimental protocol
Cultured rat glomerular mesangial cells were stimu-
lated with Ang-II after obtaining a dose–response
curve [9]. Cells were also preincubated with BQ123,
ET-1 type A receptor antagonist, or IRL1023, ET-1 type
B receptor antagonist (both from Serva Company,
Heidelberg, Germany) [10], or ET-1 antisense oligonu-
cleotide for 1 hour before stimulation with Ang-II
(Sigma Chemical Company, St Louis, MO, USA).
Thymidine uptake
Mesangial cells were brought to confluent density,
trypsinized, and counted. The medium was aspirated
and the cells were washed twice with Dulbecco’s
phosphate buffered saline (PBS) and treated with 
1 mL of 0.2% trypsin plus 0.02% ethylene diamine
tetraacetic acid (EDTA) solution for 10 minutes at
37°C. Cells were then resuspended in RPMI-1640
containing 20% FCS and were adjusted to a concen-
tration of 2 × 104 cells/mL. An aliquot of 200 μL of
cells was placed in each of the 96-well plates. The
plates were cultured for 48 hours in a 5% CO2 humid-
ified atmosphere at 37°C, and the medium was then
replaced with RPMI containing 0.5% FCS. After
adding Ang-II for 3 hours, the plates were pulsed
with 0.5 μCi of [3H]-labeled thymidine per well for 
18 hours [11]. The cells were harvested onto glass
fiber filters and washed with distilled water with a
semiautomatic cell harvester. The incorporated radio-
activity was counted with a β-scintillation counter.
All assays were performed in triplicate.
Determining the number of cells
Mesangial cells were cultured in six-well plates with
RPMI-1640 medium containing 10% FCS, 100 U/mL
penicillin, and 100 μg/mL streptomycin. After a
60–70% confluent, the medium was changed to RPMI-
1640 containing 0.5% FCS, and cultured for another 
3 days [11]. The medium was changed every 2 days,
and the number of cells was counted on the 6th day.
The cells were washed twice with PBS and treated
with 0.1% trypsin 1 mL/well for counting.
Radioimmunoassay for ET-1
The ET-1-like immunoreactivity of supernatant was
determined by a specific ET-1 radioimmunoassay
(RIA) (Peninsula Laboratories Inc., Belmont, CA,
USA) after extraction. The supernatant was applied
to a Sep-Pak C18 cartridge (Waters Associates,
Milford, MA, USA) and eluted with 5 mL 60% aceto-
nitrile in 0.1% trifluoroacetic acid. The eluate was
lyophilized and reconstituted for RIA. The antibody
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employed cross-reacted with ET-1 (100%), big ET-1
(17%), ET-2 (7%), and ET-3 (7%) and did not react
with Ang-II, vasoactive intestinal peptide or α-atrial
natriuretic peptide 1-28. The recovery rate of ET-1,
extracted through a Sep-Pak C18 column by adding
radiolabeled ET-1 to the medium, was 61.2 ± 1.2%.
The sensitivity for ET-1 RIA was 0.4 pg/tube and the
50% intercept was 20 pg/tube. The intra- and inter-
assay coefficients of variation were 9.7% and 10.5%,
respectively, over a range of concentrations between
0.1 and 64 pg/tube [12].
Measurement of fibronectin
The mesangial cells were grown in a 24-well tissue
culture plate. The medium of subconfluent cultures
was switched to Ang-II stimulation. At the end of each
experiment, the fibronectin content of the mesangial-
conditioned tissue culture supernatant was mea-
sured. Cells were then exposed to 0.05% trypsin in
0.53 mM EDTA and counted in a hemocytometer. The
primary antibody was a polyclonal rabbit anti-rat
fibronectin antiserum (Calbiochem, CA, USA), and the
secondary antibody was the peroxidase-conjugated
goat anti-IgG (Calbiochem, San Diego, CA, USA).
After incubation overnight at 4°C, the plates were
washed with TTBS (1 M Tris, pH 7.6; 5 M NaCl; 0.1%
Tween-20), stained with ECL system (Amersham,
Buckinghamshire, England), and autoradiographed
with Kodak X-OMAT-AR film [11].
Statistical analysis
Data are presented as mean ± SEM. One-way ANOVA
and unpaired t test were used to compare the differ-
ence between each pair.
RESULTS
Effects of Ang-II on ET-1 production
Both Ang-II (10−7 M) and 2% FCS enhanced ET-1 pro-
duction (p < 0.01 for Ang-II, and p < 0.001 for 2% FCS,
compared with the controls) (Figure 1).
Effects of ET-1 receptor antagonists on 
Ang-II-stimulated thymidine uptake
The baseline level of [3H]-thymidine uptake was 
significantly suppressed by BQ123 (p < 0.001) but not 
by IRL1038 (Figure 2). Ang-II (10−7 M) enhanced 
the uptake of mesangial cells significantly (p < 0.001).
The increment of Ang-II-enhanced [3H]-thymidine
uptake was not suppressed by either BQ123 or
IRL1038.
Effects of ET-1 receptor antagonists on 
Ang-II-stimulated number of cells
The baseline number of cells was significantly sup-
pressed by BQ123 (p < 0.001) but not by IRL1038
(Figure 3). Ang-II (10−7 M) enhanced the number of
cells significantly (p < 0.001), and the increment of
Ang-II-enhanced number of cells was suppressed by
BQ123 (p < 0.01) but not by IRL1038.
Effects of endothelin-1 blockers on mesangial cells
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Figure 1. Effects of angiotensin II (Ang-II, 10−7 M) and 2% fetal
calf serum (FCS) on the endothelin-1 (ET-1) production of
mesangial cells. Data are presented as mean ± SEM of all three
independent experiments performed in triplicate. *p < 0.01, †p <
0.001 compared with the control (C) without stimulation.
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Figure 2. Effects of endothelin-1 (ET-1) receptor type A antagonist
BQ123 (A, 10−6 M) and type B receptor antagonist IRL1038 (B,
10−6 M) on [3H]-thymidine uptake of glomerular mesangial cells at
24 hours. Cells were preincubated for 1 hour with either antagonist
before stimulation with angiotensin II (Ang-II, 10−7 M). *p<0.001
compared with the control (C) without adding ET-1 receptor
antagonists; †p<0.001 compared with the control (C) adding ET-1
receptor type A antagonist. Data are presented as mean±SEM of
three independent experiments performed in quadruplicate.
Effects of ET-1 receptor antagonists on 
Ang-II-stimulated production of
fibronectin protein
The baseline production of fibronectin protein was sig-
nificantly suppressed by BQ123 (p < 0.05) but not by
IRL1038 (Figure 4). Ang-II (10−7 M) enhanced fibro-
nectin production significantly (p<0.01), and the incre-
ment of Ang-II-enhanced fibronectin production was
suppressed by both BQ123 and IRL1038 (both p<0.01).
DISCUSSION
Our study indicates that Ang-II is an active stimulant
for the proliferation and fibronectin production of
glomerular mesangial cells. Ang-II is known to be 
a critical factor for the progression of chronic renal
diseases [13]. Ang-II contributes to the inflammatory
process in glomerular disorders, facilitating the
migration of mononuclear cells to the glomeruli, and
ultimately participates in the fibrotic process. These
inflammatory cells would, in turn, activate renal cells
through the release of a wide range of growth factors,
including Ang-II itself, and therefore contribute to
the perpetuation of kidney damage [14]. There is 
in vivo evidence that injured glomeruli are also sensi-
tive to local tissue actions of Ang-II, which promote
proliferation and matrix accumulation within the
glomerulus [15]. Blockade of Ang-II actions by ACE
inhibitors and angiotensin type 1 antagonists prevents
proteinuria, gene expression upregulation, fibrosis, as
well as inflammatory cell infiltration.
Ang-II affects cellular behavior by binding to cell
surface receptors [16]. Ang-II type 1 receptor antago-
nist has been found to ameliorate glomerulosclerosis
and retard the progression of chronic renal diseases
[17]. Jun-kinase mediates the proliferative effect of
Ang-II in cultured human mesangial cells and thus
represents a novel therapeutic target for the treatment
of chronic renal diseases [18]. Ang-II also promotes the
apoptosis of mesangial cells. This effect of Ang-II is
mediated through downstream signaling involving
transforming growth factor-β, phospholipase D, and
calcium, contributing to the activation of NADPH oxi-
dase and the generation of reactive oxygen species [19].
We have also demonstrated that the effects of
Ang-II on mesangial cells are partly mediated by 
ET-1. ET-1 is another vasoactive peptide involved in
glomerular diseases [3]. ET-1 was found to induce
proliferation of mesangial cells and the production 
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Figure 3. Effects of endothelin-1 receptor type A antagonist BQ123
(A, 10−6 M) and type B receptor antagonist IRL1038 (B, 10−6 M) on
the number of glomerular mesangial cells on the 6th day. Cells were
preincubated for 1 hour with either antagonist before stimulation
with angiotensin II (Ang-II, 10−7 M), and the number of cells was
counted after 6 days of culture. *p<0.001 compared with the con-
trol (C1) without any addition of drug; †p<0.01 when comparing
the increment of A2−A1 vs. C2−C1. Data are presented as mean±
SEM of three independent experiments performed in quadruplicate.
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Figure 4. Effects of endothelin-1 receptor type A antagonist BQ123
(A, 10−6 M) and type B receptor antagonist IRL1038 (B, 10−6 M)
on the fibronectin protein production of glomerular mesangial
cells. Cells were preincubated for 1 hour with either antagonist
before stimulation with angiotensin II (Ang-II, 10−7 M), and
fibronectin was measured after 24 hours of culture. *p < 0.05; †p <
0.01 compared to the baseline control without Ang-II stimulation
(C1); ‡p < 0.01 when comparing the increment of A2 −A1 vs.
C2−C1 and B2−B1 vs. C2−C1, respectively. Data are presented
as mean ± SEM of three independent experiments.
Effects of endothelin-1 blockers on mesangial cells
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of extracellular matrix [4], both of which are similar
to the action of Ang-II and therefore may explain the
possible mechanisms for the effect of Ang-II on
mesangial cells.
The synthesis of extracellular protein in mesan-
gial cells plays an important role in mesangial expan-
sion and pathogenesis of glomerulosclerosis [20].
One of the major extracellular proteins is fibronectin.
Fibronectin is a high-molecular-mass adhesive gly-
coprotein implicated in a wide variety of cellular
properties, including cell adhesion, differentiation,
proliferation, migration, and apoptosis [21]. It has
been reported that the expression of fibronectin
could be regulated by many molecules, such as trans-
forming growth factor-β, cAMP, epidermal growth
factor, platelet-derived growth factor, and interferon-γ.
However, the mechanism responsible for production
and accumulation of fibronectin remains poorly under-
stood. We have demonstrated that Ang-II increases
fibronectin production of mesangial cells, which is
mediated by ET-1. Ang-II-induced fibronectin produc-
tion can be suppressed by an RNA interference tech-
nique, which may be a new method for simultaneously
inhibiting mesangial proliferation and extracellular
matrix accumulation, and represent a novel thera-
peutic approach to glomerulosclerosis [22]. These
findings may provide new insights into the mecha-
nisms and the treatment of glomerular sclerosis asso-
ciated with Ang-II.
In conclusion, we have demonstrated that Ang-II
is an active stimulant for the proliferation and fibro-
nectin production of mesangial cells, and the effect 
is partly suppressed by ET-1 type A receptor anta-
gonists. These results support the importance of 
cross-effect between different cytokines in the regula-
tion of vascular or renal function. ET-1, and particu-
larly Ang-II, might constitute a combination in this
regulation.
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